欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/1134/001
药品名称Acnatac
活性成分
    • Clindamycin phosphate 1.2 %
    • Tretinoin 0.02 %
剂型Gel
上市许可持有人Viatris AB Sweden
参考成员国 - 产品名称Sweden (SE)
Acnex
互认成员国 - 产品名称
    • Iceland (IS)
      Acnatac 10 mg/mg + 0,25 mg/g Hlaup
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Czechia (CZ)
      Acnex
    • Slovakia (SK)
      Acnex
    • Estonia (EE)
      TRECLINAC
    • Malta (MT)
      Acnex 10mg/g + 0.25mg/g gel
    • Slovenia (SI)
    • Romania (RO)
      ACNATAC 10 mg/g + 0,25 mg/g gel
    • Cyprus (CY)
      ZIANA GEL
    • Bulgaria (BG)
      Acnex gel
    • Lithuania (LT)
      Treclinac 10 mg/0,25mg/g gelis
    • Poland (PL)
      Acnatac
    • Finland (FI)
    • Norway (NO)
    • Greece (GR)
    • Austria (AT)
    • Ireland (IE)
    • United Kingdom (Northern Ireland) (XI)
    • Luxembourg (LU)
    • Netherlands (NL)
      Treclinac 0,25 mg/g + 10 mg/g, gel
    • Belgium (BE)
      Treclinax
    • Denmark (DK)
    • Germany (DE)
      Acnex
    • Latvia (LV)
      Treclinac 10 mg/0,25 mg/g gels
许可日期2013/02/28
最近更新日期2024/10/24
药物ATC编码
    • D10AF51 clindamycin, combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Fixed combination Art 10b Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase